CLETOLIMOD

Pharmaceuticals for the therapeutic treatment of radiation exposure or sickness; Pharmaceutical compositions exhibiting anti-radiation properties; Pharmaceutical and biological preparations for the suppression and treatment of radiation sickness; Adjuvants for medical purposes, namely, for use in radiation sickness treating agents